Literature DB >> 10441344

A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies.

N Bondurand1, K Kuhlbrodt, V Pingault, J Enderich, M Sajus, N Tommerup, M Warburg, R C Hennekam, A P Read, M Wegner, M Goossens.   

Abstract

The Yemenite deaf-blind hypopigmentation syndrome was first observed in a Yemenite sister and brother showing cutaneous hypopigmented and hyperpigmented spots and patches, microcornea, coloboma and severe hearing loss. A second case, observed in a girl with similar skin symptoms and hearing loss but without microcornea or coloboma, was reported as a mild form of this syndrome. Here we show that a SOX10 missense mutation is responsible for the mild form, resulting in a loss of DNA binding of this transcription factor. In contrast, no SOX10 alteration could be found in the other, severe case of the Yemenite deaf-blind hypopigmentation syndrome. Based on genetic, clinical, molecular and functional data, we suggest that these two cases represent two different syndromes. Moreover, as mutations of the SOX10 transcription factor were previously described in Waardenburg-Hirschsprung disease, these results show that SOX10 mutations cause various types of neurocristopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10441344     DOI: 10.1093/hmg/8.9.1785

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  27 in total

1.  The transcription factor Sox10 is a key regulator of peripheral glial development.

Authors:  S Britsch; D E Goerich; D Riethmacher; R I Peirano; M Rossner; K A Nave; C Birchmeier; M Wegner
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

2.  Protein zero gene expression is regulated by the glial transcription factor Sox10.

Authors:  R I Peirano; D E Goerich; D Riethmacher; M Wegner
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 3.  Hirschsprung disease, associated syndromes, and genetics: a review.

Authors:  J Amiel; S Lyonnet
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

4.  Mice null for sox18 are viable and display a mild coat defect.

Authors:  D Pennisi; J Bowles; A Nagy; G Muscat; P Koopman
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 5.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

6.  Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.

Authors:  Olga Shakhova; Daniel Zingg; Simon M Schaefer; Lisette Hari; Gianluca Civenni; Jacqueline Blunschi; Stéphanie Claudinot; Michal Okoniewski; Friedrich Beermann; Daniela Mihic-Probst; Holger Moch; Michael Wegner; Reinhard Dummer; Yann Barrandon; Paolo Cinelli; Lukas Sommer
Journal:  Nat Cell Biol       Date:  2012-07-08       Impact factor: 28.824

Review 7.  Molecular mechanisms of optic vesicle development: complexities, ambiguities and controversies.

Authors:  Ruben Adler; M Valeria Canto-Soler
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

Review 8.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 9.  Hirschsprung disease - integrating basic science and clinical medicine to improve outcomes.

Authors:  Robert O Heuckeroth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-01-04       Impact factor: 46.802

10.  Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.

Authors:  Nadege Bondurand; Florence Dastot-Le Moal; Laure Stanchina; Nathalie Collot; Viviane Baral; Sandrine Marlin; Tania Attie-Bitach; Irina Giurgea; Laurent Skopinski; William Reardon; Annick Toutain; Pierre Sarda; Anis Echaieb; Marilyn Lackmy-Port-Lis; Renaud Touraine; Jeanne Amiel; Michel Goossens; Veronique Pingault
Journal:  Am J Hum Genet       Date:  2007-10-22       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.